Table 4.
Association Between IPV and Clinical Outcomes
| Clinical outcome | Overall | IPV | No IPV | Odds Ratioa (95% CI) | p | |||
|---|---|---|---|---|---|---|---|---|
| n = 77 | (%) | n = 30 | (%) | n = 47 | (%) | |||
| Low CD4 count (CD4 < 200) | 3.092 (0.644, 14.850) | 0.1586 | ||||||
| Yes | 8 | (10.4) | 5 | (16.7) | 3 | (6.4) | ||
| No | 69 | (89.6) | 25 | (83.3) | 44 | (93.6) | ||
| Detectable viral load | 0.431 (0.113, 1.649) | 0.2190 | ||||||
| Yes | 18 | (23.4) | 6 | (20.0) | 12 | (25.5) | ||
| No | 59 | (76.6) | 24 | (80.0) | 35 | (74.5) | ||
| 100% Adherenceb | 0.493 (0.116, 2.093) | 0.3376 | ||||||
| Yes | 67 | (88.2) | 25 | (83.3) | 42 | (91.3) | ||
| No | 9 | (11.8) | 5 | (16.7) | 4 | (8.7) | ||
| Hospitalized | 1.721 (0.488, 6.064) | 0.3984 | ||||||
| Yes | 14 | (18.4) | 6 | (20.7) | 8 | (17.0) | ||
| No | 62 | (81.6) | 23 | (79.3) | 39 | (83.0) | ||
| Tobacco usec | ||||||||
| Never | 18 | (23.4) | 8 | (26.7) | 10 | (21.3) | ||
| Former | 29 | (37.7) | 9 | (30.0) | 20 | (42.6) | 0.783 (0.215, 2.855) | 0.7105 |
| Current | 30 | (39.0) | 13 | (43.3) | 17 | (36.2) | 0.985 (0.295, 3.290) | 0.9804 |
| Illicit drug use | 2.155 (0.530, 8.756) | 0.2833 | ||||||
| Yes | 10 | (13.0) | 6 | (20.0) | 4 | (8.5) | ||
| No | 67 | (87.0) | 24 | (80.0) | 43 | (91.5) | ||
| History of other STI’s | 1.010 (0.384, 2.653) | 0.9843 | ||||||
| Yes | 36 | (46.8) | 15 | (50.0) | 21 | (44.7) | ||
| No | 41 | (53.2) | 15 | (50.0) | 26 | (55.3) | ||
| More than 1 HIV risk factor | 1.093 (0.306, 3.902) | 0.8910 | ||||||
| Yes | 14 | (18.2) | 5 | (16.7) | 9 | (19.2) | ||
| No | 63 | (81.8) | 25 | (83.3) | 38 | (80.8) | ||
| High no show rate (> 33%) | 1.689 (0.603, 4.737) | 0.3188 | ||||||
| Yes | 25 | (32.9) | 13 | (43.3) | 12 | (26.1) | ||
| No | 51 | (67.1) | 17 | (56.7) | 34 | (73.9) | ||
| Number of comorbid conditions | – | – | ||||||
| 0 | 4 | (5.8) | 1 | (3.7) | 3 | (7.1) | ||
| 1 | 22 | (31.9) | 10 | (37.0) | 12 | (28.6) | ||
| 2 | 17 | (24.6) | 9 | (33.3) | 8 | (19.1) | ||
| 3 | 9 | (13.0) | 2 | (7.4) | 7 | (16.7) | ||
| 4 | 17 | (24.6) | 5 | (18.5) | 12 | (28.6) | ||
aOdds ratios with respect to having each clinical outcome for patients experiencing IPV relative to patients not experiencing IPV, adjusted for age and new diagnosis
bAdjusted for age only
cGeneralized logits model used with ‘Never’ as the referent category